The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to respiratory disease vaccine market will help companies and investors design strategic landscapes. Viral vaccine was the largest segment with a revenue share of 54.84% in 2023. Horizon Databook has segmented the North America respiratory disease vaccine market based on viral vaccine, bacterial vaccine, combination vaccine covering the revenue growth of each sub-segment from 2018 to 2030.

Source: The North Africa Journal October 11, 2024 13:23 UTC